Message from our Chairman, Cyrus K. Mirsaidi 

Winston Churchill wrote, “Those that fail to learn from history are doomed to repeat it.” Our vision for BioSelective, though respectful of Mr. Churchill’s warning, is to repeat all the good things we’ve learned through our experiences and investments, and continually accentuate those positives.

For us, that means focus in the fields where we have deep knowledge and a competitive edge, namely biopharma and diagnostics. Further, it means a deep and genuine regard for teams that make up our portfolio companies. There’s another saying that ‘fish stinks from the head’. We apply this to our investments in companies, with investments in her people (especially the CEO), first and foremost.

Finally, we only invest in projects, and with partners, where we are valued as an ‘operating’ partner, with a seat at the table, ready to roll up our sleeves to create value for our investments and investors.